[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-344826-105":59,"doc-detail-344826-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","single-cell-transcriptomics-uncover-rnf130-mediated-tnf-pathway-activation-and-worenine-synergy-with-paclitaxel-in-breast-cancer","Single-cell transcriptomics uncover RNF130-mediated TNF-α pathway activation and worenine synergy with paclitaxel in breast cancer","","Triple-negative breast cancer (TNBC) shows high invasiveness and recurrence, yet the specific role and molecular mechanisms of RNF130 remain unclear. This study integrates TCGA and GEO transcriptomic datasets with single-cell RNA sequencing from primary breast cancer and liver metastases to define RNF130 expression, prognosis, and tumor microenvironment regulation. Functional assays in vitro and in vivo assess RNF130 effects on proliferation, apoptosis, and paclitaxel sensitivity, and evaluate Worenine as an RNF130-targeted inhibitor with paclitaxel.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/single-cell-transcriptomics-uncover-rnf130-mediated-tnf-pathway-activation-and-worenine-synergy-with-paclitaxel-in-breast-cancer/344826/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/single-cell-transcriptomics-uncover-rnf130-mediated-tnf-pathway-activation-and-worenine-synergy-with-paclitaxel-in-breast-cancer/344826.png","ImageObject",300,407,{"name":92,"@type":93},"Lucas Martin","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main focus of the study?","Question",{"text":112,"@type":113},"The study investigates how RNF130 regulates TNF-α pathway activation in TNBC and whether Worenine can synergize with paclitaxel by targeting RNF130.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers analyze RNF130 in breast cancer?",{"text":117,"@type":113},"They used large-scale transcriptomic analysis from TCGA and GEO and combined it with single-cell RNA sequencing from breast cancer samples and liver metastases to map RNF130 expression and its clinical relevance.",{"name":119,"@type":110,"acceptedAnswer":120},"What effects did RNF130 manipulation and Worenine have?",{"text":121,"@type":113},"RNF130 knockdown inhibited proliferation, induced apoptosis, reduced TNF-α pathway activation, and increased paclitaxel sensitivity; overexpression showed the opposite. Worenine decreased RNF130 expression and produced a synergistic inhibitory effect with paclitaxel.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},344826,1791475252,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},8796095360427,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Hu et al. Clinical Epigenetics (2026) 18:32 [https://doi.org/10.1186/s13148-026-02057-5](https://doi.org/10.1186/s13148-026-02057-5)  \nClinical Epigenetics  \nRESEARCH Open Access  \nSingle-cell transcriptomics uncover RNF130-mediated TNF-α pathway activation and worenine synergy with paclitaxel in breast cancer  \nMi Hu1, Liangbin Huang1, Hongzhuan Deng1, Zhifeng Chen1, Guanghui Cheng1 and Xinchun Liu 1*  \nAbstract  \nBackground Triple-negative breast cancer (TNBC) is distinguished by high invasiveness and a tendency for recurrence. Recent studies have suggested that E3 ubiquitin ligases play a crucial role in the initiation and progression of various tumors. However, there is still an absence of systematic understanding regarding the specific function and molecular mechanisms of its member gene RNF130 inTNBC.  \nMethods This study conducted a comprehensive analysis of large-scale transcriptomic data from databases such as TCGA and GEO. Additionally, single-cell RNA sequencing data from multiple breast cancer samples and their liver metastases were analyzed to evaluate the expression pattern, prognostic significance, and potential regulatory role of RNF130 in the tumor microenvironment. The effects of RNF130 on breast cancer cell proliferation, apoptosis, and chemotherapy sensitivity were explored through in vitro cell experiments and in vivo mouse models. Furthermore, the study screened and evaluated the targeted inhibitory effect of the Traditional Chinese Medicine active component Worenine on RNF130, as well as its combined therapeutic effect with paclitaxel.  \nResults The findings indicated that RNF130 was notably overexpressed in breast cancer tissues and associated with unfavorable patient survival outcomes. Single-cell transcriptomic analysis revealed that RNF130 was predominantly enriched in malignant epithelial cell populations and closely associated with tumor immune evasion phenotypes. RNF130 knockdown inhibited proliferation, induced apoptosis, reduced TNF-α pathway activation, and enhanced sensitivity to paclitaxel, whereas RNF130 overexpression exerted the opposite effects. Co-culture experiments further demonstrated that RNF130 depletion promoted M1 macrophage polarization while control cells induced M2-like phenotypes. Additionally, Worenine downregulated RNF130 expression and displayed a synergistic inhibitory effect with paclitaxel.  \nConclusion This study identifies RNF130 as a critical mediator ofTNBC progression that regulates tumor growth, apoptosis, immune evasion, and metabolic reprogramming, partly through activation oftheTNF-α signaling pathway. Furthermore, Worenine was found to reduce RNF130 expression and enhance the antitumor effect of paclitaxel,  \n*Correspondence: Xinchun Liu [xinchunliu0623@163.com](xinchunliu0623@163.com)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](vecommons.org/lice","cbCaij37vWCBkwFb","https://ap.wps.com/l/cbCaij37vWCBkwFb","pdf",14116071,22,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What is the main focus of the study?\",\"answer\":\"The study investigates how RNF130 regulates TNF-α pathway activation in TNBC and whether Worenine can synergize with paclitaxel by targeting RNF130.\"},{\"question\":\"How did the researchers analyze RNF130 in breast cancer?\",\"answer\":\"They used large-scale transcriptomic analysis from TCGA and GEO and combined it with single-cell RNA sequencing from breast cancer samples and liver metastases to map RNF130 expression and its clinical relevance.\"},{\"question\":\"What effects did RNF130 manipulation and Worenine have?\",\"answer\":\"RNF130 knockdown inhibited proliferation, induced apoptosis, reduced TNF-α pathway activation, and increased paclitaxel sensitivity; overexpression showed the opposite. Worenine decreased RNF130 expression and produced a synergistic inhibitory effect with paclitaxel.\"}]","Single-cell transcriptomics uncover RNF130-mediated TNF-α pathway activation and worenine synergy with paclitaxel in breast cancer | PDF",1790055385,55,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bf7bc0c40170556a87ffb8671f215485.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/20aee7ede73d00689cd6bc7930880b5c.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5f1086d33c8e674dbbe081bbbeb7d1f5.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b19ffe5270d73f79da4f6f4f4d3ac1ae.webp",980,1306]